Southern California Cellular Research Company Announces Publication Of "Stem Cells Targeting Inflammation As Potential Anti-Aging Strategies And Therapies" In The Scientific Journal Cell & Tissue Transplantation & Therapy

YORBA LINDA, Calif., July 10, 2015 /PRNewswire/ -- DaVinci Biosciences, LLC, a company committed to improving the quality of life for those suffering from degenerative diseases, announced today that their paper on "Stem Cells Targeting Inflammation as Potential Anti-Aging Strategies and Therapies" has been accepted for publication in the peer-reviewed journal Cell & Tissue Transplantation & Therapy.

For many years medicine has focused on prolonging lifespans and reversing the aging process. Today, anti-aging has become a major focus among the community, physicians and scientists throughout the world. As the scientific community continues researching methods to reverse aging, Dr. Rafael Gonzalez, Vice President of Research and Development of DaVinci Biosciences, Dr. Dave Woynarowski, a leading anti-aging doctor and author of the book, "The Immortality Edge" and Dr. Luis Geffner, a pioneer in the stem cell field, believe that stem cells may serve as an anti-aging strategy.

Stem cells, particularly mesenchymal stem cells, have properties that may help control inflammation. Inflammation has proven to be a key mediator in diseases of aging such as heart disease, physical disability and cognitive decline. Through research, the authors have identified that there are 3 key mediators of inflammation that can be monitored and may predict morbidity and mortality. Stem cells may help control these 3 mediators and deter the degeneration caused by the inflammatory response during aging. "We are happy to be the first to publish on the process of using stem cells as anti-aging strategies. The unique properties of stem cells could potentially benefit the aging population Inflammation plays a key role in disease and stem cells control the inflammatory process, therefore it makes sense to use stem cells to slow down that detrimental effect," stated Dr. Rafael Gonzalez. DaVinci Biosciences hopes this scientific publication will spark more interest in the use of stem cells for anti-aging strategies.

About DaVinci Biosciences LLC

DaVinci Biosciences, LLC is a cellular biology based company is dedicated to improving the quality of life for individuals suffering from degenerative disease and injury. Through responsible research and development, DaVinci strives to be innovative leaders in biotechnology and regenerative medicine; renowned worldwide for their scientific and medical achievements and contributions to the health and well-being of communities. DaVinci Biosciences is also the parent company to DV Biologics, LLC., which is a leading global supplier of human primary cells and cell-derived products. DV Biologics manufactures the highest quality biological tools for use in academic institutions and pharmaceutical laboratories engaging in cell and drug based discovery and development. DV Biologics offers normal, human-derived primary cells and cell lines for research, genomic and proteomic biological tools, and a line of disease-specific primary cells and cell lines for the most accurate study of a particular disease profile. All of DV Biologics' products are validated under the strictest quality assurance and control parameters, providing customers with reliable, guaranteed quality products for reproducible results.

DaVinci Biosciences and DV Biologics are headquartered in Yorba Linda, California.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/southern-california-cellular-research-company-announces-publication-of-stem-cells-targeting-inflammation-as-potential-anti-aging-strategies-and-therapies-in-the-scientific-journal-cell--tissue-transplantation--therapy-300111569.html

SOURCE DaVinci Biosciences, LLC